Evidence map›Paper›PMID 35224444›Full record

ReviewNanoscale advances2022

Biotechnological synthesis of Pd-based nanoparticle catalysts.

Christopher Egan-Morriss, Richard L Kimber, Nigel A Powell, Jonathan R Lloyd

Open access · goldAbstract readReview
In one paragraph

Review in Nanoscale advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Hydrogenase Mediated Biosynthesis of Catalytically Active Cu Nanoparticles.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  4. Review
  5. Review
  6. ControllingEnvironmental science & technology · 2024
    Article
  7. Article
  8. Article
  9. Will tomorrow's mineral materials be grown?Microbial biotechnology · 2023
    Article
  10. Article
  11. Reduction Kinetic of Water Soluble Metal Salts byFrontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Christopher Egan-MorrissDepartment of Earth and Environmental Sciences, Williamson Research Centre for Molecular Environmental Science, University of Manchester UK jon.lloyd@manchester.ac.uk.ORCID https://orcid.org/0000-0002-2663-6918
Richard L KimberDepartment of Environmental Geosciences, Centre for Microbiology and Environmental Systems Science, University of Vienna 1090 Vienna Austria.ORCID https://orcid.org/0000-0003-1438-4116
Nigel A PowellJohnson Matthey Technology Centre Reading RG4 9NH UK.ORCID https://orcid.org/0000-0001-5060-6359
Jonathan R LloydDepartment of Earth and Environmental Sciences, Williamson Research Centre for Molecular Environmental Science, University of Manchester UK jon.lloyd@manchester.ac.uk.ORCID https://orcid.org/0000-0002-0719-0498
University of Manchester · GBJohnson Matthey (United Kingdom) · GBUniversity of Vienna · AT

Funding

Biotechnology and Biological Sciences Research Council BB/L013711/1
6 · The paper itself

Abstract

Palladium metal nanoparticles are excellent catalysts used industrially for reactions such as hydrogenation and Heck and Suzuki C-C coupling reactions. However, the global demand for Pd far exceeds global supply, therefore the sustainable use and recycling of Pd is vital. Conventional chemical synthesis routes of Pd metal nanoparticles do not meet sustainability targets due to the use of toxic chemicals, such as organic solvents and capping agents. Microbes are capable of bioreducing soluble high oxidation state metal ions to form metal nanoparticles at ambient temperature and pressure, without the need for toxic chemicals. Microbes can also reduce metal from waste solutions, revalorising these waste streams and allowing the reuse of precious metals. Pd nanoparticles supported on microbial cells (bio-Pd) can catalyse a wide array of reactions, even outperforming commercial heterogeneous Pd catalysts in several studies. However, to be considered a viable commercial option, the intrinsic activity and selectivity of bio-Pd must be enhanced. Many types of microorganisms can produce bio-Pd, although most studies so far have been performed using bacteria, with metal reduction mediated by hydrogenase or formate dehydrogenase enzymes. Dissimilatory metal-reducing bacteria (DMRB) possess additional enzymes adapted for extracellular electron transport that potentially offer greater control over the properties of the nanoparticles produced. A recent and important addition to the field are bio-bimetallic nanoparticles, which significantly enhance the catalytic properties of bio-Pd. In addition, systems biology can integrate bio-Pd into biocatalytic processes, and processing techniques may enhance the catalytic properties further, such as incorporating additional functional nanomaterials. This review aims to highlight aspects of enzymatic metal reduction processes that can be bioengineered to control the size, shape, and cellular location of bio-Pd in order to optimise its catalytic properties.

Identifiers

PMID35224444
PMCPMC8805459
OpenAlexW4200575086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.